These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34160470)

  • 1. Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma.
    Xu Y; Yuan X; Zhang X; Hu W; Wang Z; Yao L; Zong L
    Medicine (Baltimore); 2021 Jun; 100(25):e26506. PubMed ID: 34160470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
    He CB; Lin XJ
    PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma.
    Guo J; Lv W; Wang Z; Shang Y; Yang F; Zhang X; Xiao K; Zhang S; Pan X; Han Y; Zong L; Hu W
    Cancer Control; 2023; 30():10732748221148913. PubMed ID: 36599103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Hematological Inflammatory Parameters Predict Mortality in Hepatocellular Carcinoma?
    Dertli R; Asil M; Biyik M; Karakarcayildiz A; Keskin M; Göktepe HM; Kayar Y; Ataseven H
    J Gastrointest Cancer; 2021 Jun; 52(2):666-675. PubMed ID: 32617832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.
    Sellers CM; Uhlig J; Ludwig JM; Pollak JS; Taddei TH; Stein SM; Lim JK; Kim HS
    Cancer Med; 2021 Aug; 10(16):5395-5404. PubMed ID: 34318618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
    Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
    Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
    Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE.
    Schobert IT; Savic LJ; Chapiro J; Bousabarah K; Chen E; Laage-Gaupp F; Tefera J; Nezami N; Lin M; Pollak J; Schlachter T
    Eur Radiol; 2020 Oct; 30(10):5663-5673. PubMed ID: 32424595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Pre-Operative Platelet to Lymphocyte Ratio in Patients with Resected Primary Hepatocellular Carcinoma.
    Dong L; Bai K; Cao Y; Huang Q; Lv L; Jiang Y
    Clin Lab; 2016 Nov; 62(11):2191-2196. PubMed ID: 28164677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study.
    Pang Q; Zhou L; Qu K; Cui RX; Jin H; Liu HC
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):60-70. PubMed ID: 29189392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
    Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
    World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma.
    He C; Shen W; Lin Z; Hu Z; Li H; Chen H; Yang M; Yang X; Zhuo J; Pan L; Wei X; Zhuang L; Zheng S; Lu D; Xu X
    Transpl Immunol; 2024 Aug; 85():102071. PubMed ID: 38866187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
    Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
    Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].
    Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma.
    Xu Q; Yan Y; Gu S; Mao K; Zhang J; Huang P; Zhou Z; Chen Z; Zheng S; Liang J; Lin Z; Wang J; Yan J; Xiao Z
    J Immunol Res; 2018; 2018():4925498. PubMed ID: 30027102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma.
    Kong W; Yang M; Zhang J; Cheng Y; Dai T; Zhang J; Wang G; Zhang J
    BMC Cancer; 2021 Apr; 21(1):469. PubMed ID: 33906632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.